MedTrace Logo

A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy

NCT06859801 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-02-19

No results posted yet for this study

Summary

The objective of this study is to evaluate real-world outcomes (e.g., pain, patient reported outcomes, skeletal related events, healthcare utilization, etc.) in patients treated with both percutaneous ablation and palliative radiation therapy (RT).

Conditions

  • Bone Cancer Metastatic

Interventions

DEVICE

Percutaneous Ablation

Percutaneous ablation is a minimally invasive alternative therapy for metastatic bone disease and can be used for destruction of nerves mediating pain signals, tumor destruction, decompression, or inhibition of tumor growth.

RADIATION

Radiation Therapy

Radiation therapy (RT) is a widely accepted treatment for painful bone metastases and provides palliation of pain for patients.

Sponsors & Collaborators

  • Society of Interventional Oncology

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-23
Primary Completion
2027-07-31
Completion
2027-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06859801 on ClinicalTrials.gov